Theriva Biologics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Theriva Biologics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2012-09-30 was $6.00K.
- Theriva Biologics, Inc. stock issued during period, value, stock options exercised for fiscal 2017 was $166.00K, a 79.61% decline from fiscal 2016.
- Theriva Biologics, Inc. stock issued during period, value, stock options exercised for fiscal 2016 was $814.00K, a 1885.37% increase from fiscal 2015.
- Theriva Biologics, Inc. stock issued during period, value, stock options exercised for fiscal 2015 was $41.00K, a 925.00% increase from fiscal 2014.
- Theriva Biologics, Inc. stock issued during period, value, stock options exercised for fiscal 2014 was $4.00K, a 98.28% decline from fiscal 2013.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2017-12-31 | $166.00K 10-K · filed 2019-02-27 | |
| 2016-12-31 | $814.00K 10-K · filed 2018-02-22 | |
| 2015-12-31 | $41.00K 10-K · filed 2018-02-22 | |
| 2014-12-31 | $4.00K 10-K · filed 2017-03-02 | |
| 2013-12-31 | $232.00K 10-K · filed 2016-03-10 | |
| 2012-09-30 | $6.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | |
| 2010-12-31 | $130.00K 10-K/A · filed 2012-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |